We are live on ! Find out more
SGNT

SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT

Delisted

SGNT was delisted on the 29th of August, 2016.

Back to rankings

134 hedge funds and large institutions have $418M invested in SAGENT PHARMACEUTICALS INC COM STK (DE) in 2015 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 60 increasing their positions, 30 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 30

59% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 17

9% more capital invested

Capital invested by funds: $385M → $418M (+$33M)

6% more funds holding

Funds holding: 127 → 134 (+7)

Holders
134
Holders Change
+7
Holders Change %
+5.51%
% of All Funds
3.52%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
27
Increased
60
Reduced
30
Closed
17
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
-$376K

Top Buyers

Rank Fund Capital Flow
1
EAM
Eagle Asset Management
Florida
+$10.1M
2
HM
HealthCor Management
New York
+$7.87M
3
EAM
EverPoint Asset Management
Connecticut
+$5.51M
4
SAM
Sectoral Asset Management
Quebec, Canada
+$3.54M
5
PCM
Penn Capital Management
Pennsylvania
+$3.41M

Top Sellers

Rank Fund Capital Flow
1
SCM
Scopia Capital Management
New York
-$16.8M
2
Franklin Resources
Franklin Resources
California
-$14.2M
3
State Street
State Street
Massachusetts
-$9.98M
4
RIM
Ranger Investment Management
Texas
-$2.72M
5
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado
Colorado
-$2.35M
Name Holding Trade Value Shares
Change 		Change in
Stake
Acadian Asset Management
26
Acadian Asset Management
Massachusetts
$3.69M +$2.93M +186,162 +405%
Fidelity Investments
27
Fidelity Investments
Massachusetts
$3.64M -$276K -17,500 -7%
FHAM
28
Folger Hill Asset Management
New York
$3.6M +$3.57M +226,583 New
RFC
29
Russell Frank Company
Washington
$3.52M -$1.4M -89,118 -29%
Mackenzie Financial
30
Mackenzie Financial
Ontario, Canada
$3.19M +$143K +9,100 +5%
Point72 Asset Management
31
Point72 Asset Management
Connecticut
$3.05M -$597K -37,900 -17%
Deutsche Bank
32
Deutsche Bank
Germany
$2.93M +$1.86M +117,870 +178%
Principal Financial Group
33
Principal Financial Group
Iowa
$2.51M +$116K +7,381 +5%
Morgan Stanley
34
Morgan Stanley
New York
$2.48M +$1.36M +86,578 +125%
Geode Capital Management
35
Geode Capital Management
Massachusetts
$2.41M +$69.9K +4,437 +3%
RPAM
36
Rhenman & Partners Asset Management
Sweden
$2.39M +$2.36M +150,000 New
RJA
37
Raymond James & Associates
Florida
$2.36M +$293K +18,620 +14%
TC
38
TFS Capital
Pennsylvania
$2.34M +$88.7K +5,636 +4%
ACP
39
Acuta Capital Partners
California
$2.3M -$597K -37,951 -21%
PCM
40
Piermont Capital Management
Missouri
$2.21M -$21.1K -1,340 -1%
GC
41
Guggenheim Capital
Illinois
$2.15M -$158K -10,058 -7%
Goldman Sachs
42
Goldman Sachs
New York
$1.85M -$409K -25,977 -18%
PAMU
43
Pictet Asset Management (UK)
United Kingdom
$1.78M +$398K +25,300 +29%
Ameriprise
44
Ameriprise
Minnesota
$1.75M -$34.5K -2,193 -2%
RHJA
45
Rice Hall James & Associates
California
$1.64M +$1.63M +103,230 New
JAM
46
JW Asset Management
Florida
$1.62M -$78.7K -5,000 -5%
Invesco
47
Invesco
Georgia
$1.59M +$116K +7,375 +8%
Ohio Public Employees Retirement System (OPERS)
48
Ohio Public Employees Retirement System (OPERS)
Ohio
$1.46M +$346K +22,002 +31%
BIM
49
BlackRock Investment Management
Delaware
$1.36M +$18.4K +1,170 +1%
WA
50
Whitebox Advisors
Minnesota
$1.25M -$46.2K -2,937 -4%
1
2
3 4 5

SGNT Hedge Fund Activity: Q4 2015 in Review

134 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) for Q4 2015, worth a combined $418M — up 8.6% from $385M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new SGNT positions and 17 closed out — a net gain of 10 holders — while 60 added to existing stakes and 30 trimmed.

The largest buyer was Eagle Asset Management, adding an estimated $10.1M. The largest seller was Scopia Capital Management, exiting entirely with an estimated $16.8M sold.

  • 134 institutional investors held SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) as of Q4 2015, up from 127 in Q3 2015.
  • Funds reported $418M of SAGENT PHARMACEUTICALS INC COM STK (DE) stock for Q4 2015, up 8.6% quarter-over-quarter.
  • 27 funds opened new SAGENT PHARMACEUTICALS INC COM STK (DE) positions in Q4 2015 and 17 closed out, a net change of +10 holders.
  • The largest SAGENT PHARMACEUTICALS INC COM STK (DE) buyer in Q4 2015 was Eagle Asset Management, an estimated $10.1M added.
  • The largest SAGENT PHARMACEUTICALS INC COM STK (DE) seller in Q4 2015 was Scopia Capital Management, an estimated $16.8M sold.

Based on aggregated 13F filings for Q4 2015.